Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke | Zendy

Li Zhang | Zendy; Michael Chopp | Zendy; Hua Teng | Zendy; Guangliang Ding | Zendy; Quan Jiang | Zendy; Xiao Yang | Zendy; Nour Eddine Rhaleb | Zendy; Zheng Gang Zhang | Zendy

Open Access

Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke

Author(s) -

Li Zhang,

Michael Chopp,

Hua Teng,

Guangliang Ding,

Quan Jiang,

Xiao Yang,

Nour Eddine Rhaleb,

Zheng Gang Zhang

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.004399

Subject(s) - medicine , neuroprotection , tissue plasminogen activator , plasminogen activator , stroke (engine) , pharmacology , fibrin , plasminogen activator inhibitor 1 , t plasminogen activator , fibrinolytic agent , brain ischemia , ischemia , endocrinology , immunology , mechanical engineering , engineering

N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP), an endogenously produced circulating peptide in humans and rodents, exerts anti-inflammatory and cardioprotective activities in various cardiovascular diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research